Tetraphase Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TTPH and buy or sell other stocks, ETFs, and their options commission-free!About TTPH
Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections.
CEOLarry Edwards
CEOLarry Edwards
Employees—
Employees—
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2006
Founded2006
Employees—
Employees—
TTPH Key Statistics
Market cap15.98M
Market cap15.98M
Price-Earnings ratio-0.12
Price-Earnings ratio-0.12
Dividend yield—
Dividend yield—
Average volume185.26K
Average volume185.26K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.60
52 Week high$8.60
52 Week low$0.56
52 Week low$0.56
Stock Snapshot
Tetraphase Pharmaceuticals(TTPH) stock is priced at $2.20, giving the company a market capitalization of 15.98M. It carries a P/E multiple of -0.12.
On 2026-01-01, Tetraphase Pharmaceuticals(TTPH) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 185.26K.
Over the past 52 weeks, Tetraphase Pharmaceuticals(TTPH) stock has traded between a high of $8.60 and a low of $0.56.
Over the past 52 weeks, Tetraphase Pharmaceuticals(TTPH) stock has traded between a high of $8.60 and a low of $0.56.